SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-24-007516
Filing Date
2024-01-12
Accepted
2024-01-12 16:11:34
Documents
6
Effectiveness Date
2024-01-12

Document Format Files

Seq Description Document Type Size
1 S-8 d611393ds8.htm S-8 50113
2 EX-5.1 d611393dex51.htm EX-5.1 8525
3 EX-23.1 d611393dex231.htm EX-23.1 1624
4 EX-99.5 d611393dex995.htm EX-99.5 111277
5 EX-FILING FEES d611393dexfilingfees.htm EX-FILING FEES 23908
6 GRAPHIC g611393page007.jpg GRAPHIC 4353
  Complete submission text file 0001193125-24-007516.txt   202662
Mailing Address 4224 CAMPUS POINT COURT SUITE 210 SAN DIEGO CA 92121
Business Address 4224 CAMPUS POINT COURT SUITE 210 SAN DIEGO CA 92121 858-202-6300
Regulus Therapeutics Inc. (Filer) CIK: 0001505512 (see all company filings)

IRS No.: 264738379 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-276484 | Film No.: 24532160
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)